Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: twt who wrote (619)	11/25/1998 5:26:00 PM
From: John F Beule	Read Replies (1) \| Respond to of 2539

Anthony, that article IMO this is proof that the management team at MTC has extremely savvy focus, they are way ahead in the biotech/ag ballgame, and the big money is coming out of the closet after this fact is realized. This tells me that MTC got excellent prices for their acquisitions, and they were smart for not going with AHP because of the intrinsic value that is now becoming apparent because of all these folks clamoring to divest themselves to re-direct into bio/ag. twt As an armchair TA chartist, if MTC can get at $45, and stay there for awhile to base, the next move is a huge gap up. Still going long....